The observation that therapy with IL-1β antagonists results in a rapid and sustained reduction in disease severity of many autoinflammatory disease including TRAPS indicates that these diseases are predominately mediated by the IL-1 cytokine family [42]. This evidence concerns the gene IL1B and TNF receptor 1-associated periodic fever syndrome.